Clinical Trial Update: Imaging Malignant Glioma With 68Ga-DOTATOC PET/CT [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating imaging of malignant glioma with the radiotracer 68Ga-DOTATOC PET/CT has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• 68Ga-DOTATOC (DOTATOC)

Snippet

Sponsor: Turku University Hospital | Conditions: Glioma | Phase 2, Phase 3 | Status: COMPLETED